In8Bio (INAB) Current Leases (2021 - 2026)
In8Bio (INAB) posted Current Leases of $189000.0 for Q1 2026, down 79.55% sequentially from $924000.0 in Q4 2025, and down 67.19% YoY from $576000.0 in Q1 2025.
In8Bio (INAB) Current Leases (2021 - 2026) Analysis & Trends
In8Bio has reported Current Leases for 6 years, with the latest figure at $189000.0 in Q1 2026.
- Quarterly Current Leases fell 67.19% year-over-year to $189000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $189000.0 (down 67.19% YoY) and the FY2025 annual result came in at $924000.0, up 33.14% from the prior year.
- Current Leases slipped to $189000.0 in Q1 2026 per INAB's latest filing, from $924000.0 in the prior quarter.
- Over five years, Current Leases peaked at $924000.0 in Q4 2025 and troughed at $189000.0 in Q1 2026.
- A 5-year average of $588588.2 and a median of $680000.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2026: Current Leases soared 202.14% in 2022, then tumbled 67.19% in 2026.
- Over 5 years, Current Leases stood at $707000.0 in 2022, then declined by 1.84% to $694000.0 in 2023, then changed by 0.0% to $694000.0 in 2024, then soared by 33.14% to $924000.0 in 2025, then tumbled by 79.55% to $189000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $189000.0, $924000.0, and $343000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | - |
| 10 | In8Bio | 23.75 Mn | 23.75 Mn | - | 923,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 923,000.00 |
| Mar 31, 2026 | 189,000.00 |
| Dec 31, 2025 | 924,000.00 |
| Sep 30, 2025 | 343,000.00 |
| Jun 30, 2025 | 404,000.00 |
| Mar 31, 2025 | 576,000.00 |
| Dec 31, 2024 | 694,000.00 |
| Sep 30, 2024 | 920,000.00 |
| Jun 30, 2024 | 887,000.00 |
| Mar 31, 2024 | 680,000.00 |
| Dec 31, 2023 | 694,000.00 |
| Sep 30, 2023 | 715,000.00 |
| Jun 30, 2023 | 757,000.00 |
| Mar 31, 2023 | 654,000.00 |
| Dec 31, 2022 | 707,000.00 |
| Sep 30, 2022 | 276,000.00 |
| Jun 30, 2022 | 261,000.00 |
| Mar 31, 2022 | 325,000.00 |
| Dec 31, 2021 | 234,000.00 |
| Sep 30, 2021 | 164,000.00 |